Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema.

類似資料

• Simulation studies of surrogate endpoint validation using single trial and multitrial statistical approaches.
  著者:: Lassere, M, 等
  出版事項: (2007)
• Is blood pressure reduction a valid surrogate endpoint for stroke prevention? an analysis incorporating a systematic review of randomised controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) and the biomarker-surrogacy (BioSurrogate) evaluation schema (BSES)
  著者:: Lassere Marissa N, 等
  出版事項: (2012-03-01)
• Biomarkers and surrogate endpoints.
  著者:: Aronson, J
  出版事項: (2005)
• A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials
  著者:: Ciani, O, 等
  出版事項: (2023)
• Defining surrogate endpoints for clinical trials in severe Falciparum malaria.
  著者:: Jeeyapant, A, 等
  出版事項: (2017)